You are here

Structural & Congenital Heart Disease

 

For patients with severe aortic stenosis (AS) at intermediate surgical risk, transcatheter aortic valve replacement (TAVR)—especially the transfemoral approach—might be a good solution.

Transcatheter aortic valve implantation (TAVI) has skyrocketed in the United States, jumping from 24.8 implants per million adults in 2012 to 63.2 in 2014. A recent study examined regional differences in mortality, utilization and healthcare resource use.

Infants with congenital heart disease (CHD) born post-term and with the most body weight have the best chance of surviving for five years, while lighter, preterm babies have poorer chances, according to new research.

All sizes of the Portico TAVR system resulted in effective and safe short-term treatment of high-risk patients, according to a new study.

Compared with six other scales that measure frailty, one called the Essential Frailty Toolset stands out for its ability to predict mortality 30 days after two types of valve replacement surgery. It can also predict worsening disability at one year, according to a new study.

 

Recent Headlines

TAVR, SAVR produce similar long-term health gains

For patients with severe aortic stenosis (AS) at intermediate surgical risk, transcatheter aortic valve replacement (TAVR)—especially the transfemoral approach—might be a good solution.

TAVI utilization rate highest Northeast US; mortality highest in South

Transcatheter aortic valve implantation (TAVI) has skyrocketed in the United States, jumping from 24.8 implants per million adults in 2012 to 63.2 in 2014. A recent study examined regional differences in mortality, utilization and healthcare resource use.

Birth weight strongly predictive of survival in infants with congenital heart disease

Infants with congenital heart disease (CHD) born post-term and with the most body weight have the best chance of surviving for five years, while lighter, preterm babies have poorer chances, according to new research.

Study: All Portico heart valve sizes demonstrate effective short-term performance

All sizes of the Portico TAVR system resulted in effective and safe short-term treatment of high-risk patients, according to a new study.

Risk of stroke in AFib patients associated with aortic curvature

Atrial fibrillation (AFib) heightens stroke risk—but new research shows that this is true only in people with certain aortic shapes. Those with aortic arches that are less curved are more prone to stroke, according to a study published online Aug. 1 in Nature.

Scientists use CRISPR to erase cardiomyopathy mutation in human embryos

CRISPR is capable of targeting specific stretches of genetic code and editing DNA. Researchers have used the tool to erase a genetic mutation that causes hypertrophic cardiomyopathy in human embryos.

Essential Frailty Toolset outperforms others in predicting mortality after TAVR, SAVR

Compared with six other scales that measure frailty, one called the Essential Frailty Toolset stands out for its ability to predict mortality 30 days after two types of valve replacement surgery. It can also predict worsening disability at one year, according to a new study.

Stroke is increasing in younger populations—but why?

With recent research suggesting that strokes among younger people are becoming more prevalent, healthcare professionals are looking into why.

Printing 3D hearts

3D printers have created the darnedest things: acoustic guitars that strum and guns that shoot, women’s high-heeled shoes, lights, clocks and even custom-fitted fabric.

AHA recognizes Penn Medicine cardiology researchers

The American Heart Association (AHA) has awarded Benjamin L. Prosser, PhD, a professor at the University of Pennsylvania, its Outstanding Early Career Investigator Award.

Pages